Pros and Cons: Should the Mets trade for Drew Rasmussen?

The Mets face a critical decision regarding their starting rotation for the 2027 season. Their current rotation is lacking in depth and relies too heavily on bounce-backs from previous years. Two potential solutions include signing free agents like Tarik Skubal, who is considered one of the best pitchers in the game, or pursuing Drew Rasmussen through a trade.

Rasmussen has been a dominant force in the Major Leagues since his debut in 2021. In 2026, he posted a 2.67 ERA and a league-leading 0.91 WHIP, allowing only 125 hits in 172 innings. His advanced metrics indicate that he is an elite pitcher, with a fastball ranked in the 99th percentile and an off-speed run value in the 93rd percentile. Despite missing time due to elbow surgery in 2023 and 2024, Rasmussen has made 30+ starts each of his last two seasons, maintaining strong velocities.

However, there are significant risks associated with acquiring Rasmussen. His health is a major concern, as he has already undergone two Tommy John surgeries and an internal brace procedure. If another elbow injury occurs, it could be devastating for the Mets. Since Rasmussen is only under team control for one season, the Mets would mitigate this risk by not committing to a long-term contract.

Additionally, the cost of acquiring Rasmussen could be high, especially considering the $20 million he is owed in 2027. However, this cost could be offset by the $20 million he is owed and the fact that he is a one-year rental. Moreover, the Mets could still pursue other free agents like Skubal, Holmes, or King, which would not be precluded by acquiring Rasmussen through a trade.

In conclusion, while there are risks associated with acquiring Rasmussen, his proven track record and elite pitching metrics make him a strong candidate for the Mets' top rotation spot. The team must weigh these pros and cons carefully as they navigate the offseason and make strategic decisions for the upcoming season.